Loading...
Loading...
Gainers
- Grifols, Inc. GRFS stock moved upwards by 1.3% to $20.10 during Tuesday's pre-market session. The market cap seems to be at $17.8 billion.
- MorphoSys, Inc. MOR shares rose 1.1% to $26.93. The market value of their outstanding shares is at $3.6 billion.
- Advaxis, Inc. ADXS stock moved upwards by 1.0% to $0.37. The market cap stands at $6.1 million.
Losers
- Qiagen, Inc. QGEN stock plummeted 18.9% to $26.00 during Tuesday's pre-market session. The market value of their outstanding shares is at $7.4 billion. The most recent rating by JP Morgan, on October 08, is at Underweight, with a price target of $25.00.
- Nektar Therapeutics, Inc. NKTR stock plummeted 7.0% to $17.37. The market value of their outstanding shares is at $3.3 billion. The most recent rating by Goldman Sachs, on October 08, is at Sell, with a price target of $16.00.
- DBV Technologies, Inc. DBVT stock decreased by 6.3% to $7.70. The market cap seems to be at $620.4 million.
- Capricor Therapeutics, Inc. CAPR stock declined 3.6% to $2.90. The market value of their outstanding shares is at $11.7 million. The most recent rating by H.C. Wainwright, on July 15, is at Buy, with a price target of $12.40.
- Genfit, Inc. GNFT shares decreased by 2.7% to $13.23. The market cap stands at $624.4 million.
- Xenetic Biosciences, Inc. XBIO shares declined 2.3% to $1.27. The market cap seems to be at $6.5 million.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneralHealthcare Stocks Pre-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in